John Didsbury is the founder of T3D Therapeutics. T3D Therapeutics has raised $34M in total funding. Latest round: Series A. Backed by cornerstone investor.
John Didsbury is the founder of T3D Therapeutics, which he founded in 2013. He currently serves as Chairman, President, and Chief Executive Officer at the company. T3D Therapeutics is a clinical-stage drug development company focused on treatments for Alzheimer’s disease.
Full founder directory · Investor directory · Company funding database · Fundraising library